Cover Image
市場調查報告書

的血液學市場預測EU5個國家

EU5 Haematology Market Outlook to 2021

出版商 GlobalData 商品編碼 348473
出版日期 內容資訊 英文 256 Pages
訂單完成後即時交付
價格
Back to Top
的血液學市場預測EU5個國家 EU5 Haematology Market Outlook to 2021
出版日期: 2015年10月05日 內容資訊: 英文 256 Pages
簡介

本報告提供EU5個國家血液學市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 EU5個國家的血液學市場

  • 收益
  • 類別比較:各收益
  • 收益實際成果
  • 收益預測
  • 企業佔有率:各收益

第4章 法國的血液學市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 德國的血液學市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 義大利的血液學市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 西班牙的血液學市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第8章 英國的血液學市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第9章 EU5個國家的血液學市場主要企業概要

  • Siemens Healthcare
  • Sysmex Corporation
  • F. Hoffmann-La Roche Ltd
  • 堀場製作所
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Diagnostica Stago, Inc.

第10章 血液學市場開發中產品

第11章 最近的發展

  • 企業宣傳
  • 公佈財報
  • 法律規章
  • 其他重要的發展
  • 產品新聞
  • 策略和產業計畫

第12章 附錄

圖表

目錄
Product Code: GDMECR0330DB

GlobalData's new report, "EU5 Haematology Market Outlook to 2021", provides key market data on the EU5 Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Haematology market.
  • Global corporate-level profiles of key companies operating within the EU5 Haematology market.
  • Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Haematology Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Haematology Market, EU5

  • 3.1. Haematology Market, EU5, Revenue ($m), 2007-2021
  • 3.2. Haematology Market, EU5, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Haematology Market, EU5, Revenue ($m), 2007-2014
  • 3.4. Haematology Market, EU5, Revenue ($m), 2014-2021
  • 3.5. Haematology Market, EU5, Company Share by Revenue ($m), 2014

4. Haematology Market, France

  • 4.1. Haematology Market, France, Revenue ($m), 2007-2014
  • 4.2. Haematology Market, France, Revenue ($m), 2014-2021
    • 4.2.1. Haematology Cell Counters Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Haematology Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.3. Haematology Reagents Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.4. Haemostasis Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.5. Immunohaematology Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.6. Haematology Cell Counters Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.7. Haematology Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.8. Haematology Reagents Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.9. Haemostasis Market, France, Revenue ($m), by Segment, 2014-2021
    • 4.2.10. Immunohaematology Market, France, Revenue ($m), by Segment, 2014-2021
  • 4.3. Haematology Market, France, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Haematology Market, France, Company Share by Revenue ($m), 2014

5. Haematology Market, Germany

  • 5.1. Haematology Market, Germany, Revenue ($m), 2007-2014
  • 5.2. Haematology Market, Germany, Revenue ($m), 2014-2021
    • 5.2.1. Haematology Cell Counters Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Haematology Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.3. Haematology Reagents Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.4. Haemostasis Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.5. Immunohaematology Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.6. Haematology Cell Counters Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.7. Haematology Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.8. Haematology Reagents Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.9. Haemostasis Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 5.2.10. Immunohaematology Market, Germany, Revenue ($m), by Segment, 2014-2021
  • 5.3. Haematology Market, Germany, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Haematology Market, Germany, Company Share by Revenue ($m), 2014

6. Haematology Market, Italy

  • 6.1. Haematology Market, Italy, Revenue ($m), 2007-2014
  • 6.2. Haematology Market, Italy, Revenue ($m), 2014-2021
    • 6.2.1. Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Haematology Rapid Tests & POC Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.4. Haemostasis Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.5. Immunohaematology Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.6. Haematology Cell Counters Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.7. Haematology Rapid Tests & POC Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.8. Haematology Reagents Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.9. Haemostasis Market, Italy, Revenue ($m), by Segment, 2014-2021
    • 6.2.10. Immunohaematology Market, Italy, Revenue ($m), by Segment, 2014-2021
  • 6.3. Haematology Market, Italy, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Haematology Market, Italy, Company Share by Revenue ($m), 2014

7. Haematology Market, Spain

  • 7.1. Haematology Market, Spain, Revenue ($m), 2007-2014
  • 7.2. Haematology Market, Spain, Revenue ($m), 2014-2021
    • 7.2.1. Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Haematology Rapid Tests & POC Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.3. Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.4. Haemostasis Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.5. Immunohaematology Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.6. Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.7. Haematology Rapid Tests & POC Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.8. Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.9. Haemostasis Market, Spain, Revenue ($m), by Segment, 2014-2021
    • 7.2.10. Immunohaematology Market, Spain, Revenue ($m), by Segment, 2014-2021
  • 7.3. Haematology Market, Spain, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Haematology Market, Spain, Company Share by Revenue ($m), 2014

8. Haematology Market, United Kingdom

  • 8.1. Haematology Market, United Kingdom, Revenue ($m), 2007-2014
  • 8.2. Haematology Market, United Kingdom, Revenue ($m), 2014-2021
    • 8.2.1. Haematology Cell Counters Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.3. Haematology Reagents Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.4. Haemostasis Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.5. Immunohaematology Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.6. Haematology Cell Counters Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.7. Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.8. Haematology Reagents Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.9. Haemostasis Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 8.2.10. Immunohaematology Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
  • 8.3. Haematology Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014
  • 8.4. Haematology Market, United Kingdom, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in EU5 Haematology Market

  • 9.1. Siemens Healthcare
    • 9.1.1. Company Overview
  • 9.2. Sysmex Corporation
    • 9.2.1. Company Overview
  • 9.3. F. Hoffmann-La Roche Ltd.
    • 9.3.1. Company Overview
  • 9.4. Horiba, Ltd.
    • 9.4.1. Company Overview
  • 9.5. Bio-Rad Laboratories, Inc.
    • 9.5.1. Company Overview
  • 9.6. Danaher Corporation
    • 9.6.1. Company Overview
  • 9.7. Abbott Laboratories
    • 9.7.1. Company Overview
  • 9.8. Diagnostica Stago, Inc.
    • 9.8.1. Company Overview

10. Haematology Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Sep 14, 2015: ABCAM: Directorate Changes
    • 11.1.2. Jul 27, 2015: Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt
    • 11.1.3. Jun 29, 2015: ABCAM Appoints Chief Legal Officer and Company Secretary
    • 11.1.4. Jun 15, 2015: Intra-Cellular Therapies Reports Completion of Enrollment With 450 Patients Randomized in the ITI-007-301 Phase 3 Clinical Trial for the Treatment of Schizophrenia
    • 11.1.5. May 08, 2015: Change in Roche Board of Directors
    • 11.1.6. Mar 19, 2015: Novartis To Eliminate 89 Jobs At Suffern Facility
    • 11.1.7. Dec 12, 2014: Abcam Announces Board Appointment
    • 11.1.8. Nov 18, 2014: Ablynx Appoints Johan Heylen As Chief Commercial Officer
    • 11.1.9. Oct 30, 2014: Novartis Lays Off 75 Employees At Lincoln Plant
  • 11.2. Financial Announcements
    • 11.2.1. Sep 16, 2015: WaferGen Presents Results From Company's Single-Cell System at the Single Cell Genomics Meeting
    • 11.2.2. Sep 14, 2015: ABCAM: Preliminary Results for the Year Ended 30 June 2015`
    • 11.2.3. Aug 27, 2015: Ablynx Announces Half-Year Results For 2015
    • 11.2.4. Jul 23, 2015: Roche delivers strong performance in the first half of 2015
    • 11.2.5. Jun 04, 2015: Roche receives FDA clearance for the cobas Cdiff Test to detect Clostridium difficile
    • 11.2.6. Apr 23, 2015: Novartis delivered sales growth, significant margin expansion and strong innovation in Q1; now with a more focused portfolio
    • 11.2.7. Apr 22, 2015: Roche reports strong sales growth in the first quarter of 2015
    • 11.2.8. Apr 01, 2015: BTG begins sale of DC Bead and Bead Block directly to Physicians
    • 11.2.9. Mar 30, 2015: 100th Patent in Three Years: The Result of a Successful Patent Strategy
    • 11.2.10. Mar 09, 2015: Abcam: Interim Results for the Six Months Ended 31 December 2014
    • 11.2.11. Feb 26, 2015: Ablynx Announces 2014 Full Year Results
    • 11.2.12. Feb 26, 2015: Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014
    • 11.2.13. Jan 27, 2015: Novartis Reports Finanical Results for Fourth Quarter of 2014
    • 11.2.14. Jan 26, 2015: Heat Biologics Presents Positive Immunological Data on HS-410 in Non-Muscle Invasive Bladder Cancer at the 7th Annual Phacilitate Immunotherapy Forum 2015
    • 11.2.15. Jan 26, 2015: Ipsen announces topline results of two double-blind phase III studies of Dysport in lower limb spasticity in children and in adults
    • 11.2.16. Nov 13, 2014: Ablynx Announces Its Business Update For The First Nine Months Of 2014
    • 11.2.17. Nov 04, 2014: Grifols Net Profit Increases By 26.9% To 339 Million Euros In The Nine Months To September 2014
    • 11.2.18. Oct 28, 2014: Novartis delivered solid sales growth with strong margin expansion and major innovation in the third quarter
  • 11.3. Legal And Regulatory
    • 11.3.1. Feb 16, 2015: Grifols PhocusRx Certified DIACAP Compliant
    • 11.3.2. Jan 22, 2015: Ablynx Successfully Opposes Patent Appeal Case By Domantis
    • 11.3.3. Jan 21, 2015: Grifols Academy of Plasmapheresis Awarded ACCET Accreditation
    • 11.3.4. Jan 02, 2015: Grifols new immunoglobulin purification plant in the United States receives FDA approval
  • 11.4. Other Significant Developments
    • 11.4.1. Sep 11, 2015: For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
    • 11.4.2. Jul 21, 2015: Novartis delivered solid performance in the second quarter, with strong innovation and progress on new launches
    • 11.4.3. Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
    • 11.4.4. Oct 02, 2014: Siemens, Inpeco and Quest Diagnostics Join Forces to Build the Lab of the Future
  • 11.5. Product News
    • 11.5.1. Jun 22, 2015: Roche unveils powerful innovations in diagnostics at EuroMedLab
    • 11.5.2. Mar 18, 2015: Tumour determination in bowel cancer: blood test replaces surgery
    • 11.5.3. Dec 16, 2014: Irish company at advanced stage of testing a treatment for Ebola
    • 11.5.4. Nov 13, 2014: Randox Launches Data Management Advisor To Optimise Lab Quality Control
  • 11.6. Strategy And Business Planning
    • 11.6.1. Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters
    • 11.6.2. Jul 07, 2015: Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy
    • 11.6.3. Jul 01, 2015: Roche lays foundation stone of new IT innovation centre in Kaiseraugst
    • 11.6.4. Jun 30, 2015: ISD completes single envelope 'clad rack' cold storage facility for Spanish pharmaceutical giant Grifols
    • 11.6.5. Jan 19, 2015: Roche opens new Learning Center in Kaiseraugst
    • 11.6.6. Jan 17, 2015: Novartis To Shutdown Manufacturing Facility In Puerto Rico
    • 11.6.7. Jan 14, 2015: Randox Strengthens Regional Commitment with Expansion Plans in County Antrim
    • 11.6.8. Nov 27, 2014: Diagnostics Leader Delivers New Fertility Service For UK
    • 11.6.9. Oct 20, 2014: Randox Teoranta sets out new vision with Dungloe 2020

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Haematology Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Haematology Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Haematology Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Haematology Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Haematology Market, EU5, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Haematology Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Haematology Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 17: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 18: Haematology Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 19: Haematology Market, France, Company Share by Revenue ($m), USD Constant, 2014
  • Table 20: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 23: Haematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 24: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 26: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Haematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 29: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 30: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 31: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 33: Haematology Market, Germany, Company Share by Revenue ($m), USD Constant, 2014
  • Table 34: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 35: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 37: Haematology Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 38: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 39: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 41: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 42: Haematology Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 43: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 44: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 45: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Haematology Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 47: Haematology Market, Italy, Company Share by Revenue ($m), USD Constant, 2014
  • Table 48: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 50: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Haematology Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 54: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 55: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: Haematology Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Haematology Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Haematology Market, Spain, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 63: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 64: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 65: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 67: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 68: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 69: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 70: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 71: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 73: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Haematology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Haematology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: Haematology Market Pipeline Products

List of Figures

  • Figure 1: Haematology Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Haematology Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Haematology Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Haematology Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Haematology Market, EU5, Company Share (%) 2014
  • Figure 6: Haematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Haematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Haematology Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Haematology Reagents Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Haemostasis Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Immunohaematology Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Haematology Cell Counters Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 14: Haematology Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Haematology Reagents Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Haemostasis Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Immunohaematology Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Haematology Market, France, Company Share (%) 2014
  • Figure 19: Haematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 20: Haematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 21: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Haematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 23: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 24: Haemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 25: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 26: Haematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 27: Haematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 29: Haemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 30: Immunohaematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 31: Haematology Market, Germany, Company Share (%) 2014
  • Figure 32: Haematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 35: Haematology Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 36: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 37: Haemostasis Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 38: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 39: Haematology Cell Counters Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 40: Haematology Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 41: Haematology Reagents Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 42: Haemostasis Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Immunohaematology Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 44: Haematology Market, Italy, Company Share (%) 2014
  • Figure 45: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 46: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 47: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 48: Haematology Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 53: Haematology Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 54: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 55: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Haematology Market, Spain, Company Share (%) 2014
  • Figure 58: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 59: Haematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 61: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 62: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 63: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 64: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 65: Haematology Cell Counters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 66: Haematology Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Haematology Reagents Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 68: Haemostasis Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Immunohaematology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 70: Haematology Market, United Kingdom, Company Share (%) 2014
Back to Top